APA

Makhoul I., Todorova V. K., Siegel E. R., Erickson S. W., Dhakal I., Raj V. R., Lee J. Y., Orloff M. S., Griffin R. J., Henry-Tillman R. S., Klimberg S., Hutchins L. F. & Kadlubar S. A. (20170821). Germline Genetic Variants in TEK, ANGPT1, ANGPT2, MMP9, FGF2 and VEGFA Are Associated with Pathologic Complete Response to Bevacizumab in Breast Cancer Patients. : PloS one.

Chicago

Makhoul Issam, Todorova Valentina K, Siegel Eric R, Erickson Stephen W, Dhakal Ishwori, Raj Vinay R, Lee Jeannette Y, Orloff Mohammed S, Griffin Robert J, Henry-Tillman Ronda S, Klimberg Suzanne, Hutchins Laura F and Kadlubar Susan A. 20170821. Germline Genetic Variants in TEK, ANGPT1, ANGPT2, MMP9, FGF2 and VEGFA Are Associated with Pathologic Complete Response to Bevacizumab in Breast Cancer Patients. : PloS one.

Harvard

Makhoul I., Todorova V. K., Siegel E. R., Erickson S. W., Dhakal I., Raj V. R., Lee J. Y., Orloff M. S., Griffin R. J., Henry-Tillman R. S., Klimberg S., Hutchins L. F. and Kadlubar S. A. (20170821). Germline Genetic Variants in TEK, ANGPT1, ANGPT2, MMP9, FGF2 and VEGFA Are Associated with Pathologic Complete Response to Bevacizumab in Breast Cancer Patients. : PloS one.

MLA

Makhoul Issam, Todorova Valentina K, Siegel Eric R, Erickson Stephen W, Dhakal Ishwori, Raj Vinay R, Lee Jeannette Y, Orloff Mohammed S, Griffin Robert J, Henry-Tillman Ronda S, Klimberg Suzanne, Hutchins Laura F and Kadlubar Susan A. Germline Genetic Variants in TEK, ANGPT1, ANGPT2, MMP9, FGF2 and VEGFA Are Associated with Pathologic Complete Response to Bevacizumab in Breast Cancer Patients. : PloS one. 20170821.